Download
PIIS2542519619302438.pdf 1,40MB
WeightNameValue
1000 Titel
  • Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels: a prospective genomic study
1000 Autor/in
  1. El-Kafrawy, Sherif A. |
  2. Corman, Victor M. |
  3. Tolah, Ahmed M. |
  4. Al Masaudi, Saad B. |
  5. Hassan, Ahmed M. |
  6. Müller, Marcel A. |
  7. Bleicker, Tobias |
  8. Harakeh, Steve M. |
  9. Alzahrani, Abdulrahman A. |
  10. Alsaaidi, Ghaleb A. |
  11. Alagili, Abdulaziz N. |
  12. Hashem, Anwar M. |
  13. Zumla, Alimuddin |
  14. Drosten, Christian |
  15. Azhar, Esam I. |
1000 Erscheinungsjahr 2019
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2019-12-01
1000 Erschienen in
1000 Quellenangabe
  • 3(12):e521-e528
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2019
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/S2542-5196(19)30243-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926486/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen endemic to the Arabian Peninsula. Dromedary camels are a likely source of infection and the virus probably originated in Africa. We studied the genetic diversity, geographical structure, infection prevalence, and age-associated prevalence among camels at the largest entry port of camels from Africa into the Arabian Peninsula. METHODS: In this prospective genomic study, we took nasal samples from camels imported from Sudan and Djibouti into the Port of Jeddah in Jeddah, Saudi Arabia, over an almost 2-year period and local Arabian camels over 2 months in the year after surveillance of the port. We determined the prevalence of MERS-CoV infection, age-associated patterns of infection, and undertook phylogeographical and migration analyses to determine intercountry virus transmission after local lineage establishment. We compared all virological characteristics between the local and imported cohorts. We compared major gene deletions between African and Arabian strains of the virus. Reproductive numbers were inferred with Bayesian birth death skyline analyses. FINDINGS: Between Aug 10, 2016, and May 3, 2018, we collected samples from 1196 imported camels, of which 868 originated from Sudan and 328 from Djibouti, and between May 1, and June 25, 2018, we collected samples from 472 local camels, of which 189 were from Riyadh and 283 were from Jeddah, Saudi Arabia. Virus prevalence was higher in local camels than in imported camels (224 [47•5%] of 472 vs 157 [13•1%] of 1196; p<0•0001). Infection prevalence peaked among camels older than 1 year and aged up to 2 years in both groups, with 255 (66•9%) of 381 positive cases in this age group. Although the overall geographical distribution of the virus corresponded with the phylogenetic tree topology, some virus exchange was observed between countries corresponding with trade routes in the region. East and west African strains of the virus appear to be geographically separated, with an origin of west African strains in east Africa. African strains of the virus were not re-sampled in Saudi Arabia despite sampling approximately 1 year after importation from Africa. All local Arabian samples contained strains of the virus that belong to a novel recombinant clade (NRC) first detected in 2014 in Saudi Arabia. Reproduction number estimates informed by the sequences suggest sustained endemicity of NRC, with a mean Re of 1•16. INTERPRETATION: Despite frequent imports of MERS-CoV with camels from Africa, African lineages of MERS-CoV do not establish themselves in Saudi Arabia. Arabian strains of the virus should be tested for changes in virulence and transmissibility.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal MERS-CoV
lokal Coronavirus
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/RWwtS2FmcmF3eSwgU2hlcmlmIEEu|https://frl.publisso.de/adhoc/uri/Q29ybWFuLCBWaWN0b3IgTS4=|https://frl.publisso.de/adhoc/uri/VG9sYWgsIEFobWVkIE0u|https://frl.publisso.de/adhoc/uri/QWwgTWFzYXVkaSwgU2FhZCBCLg==|https://frl.publisso.de/adhoc/uri/SGFzc2FuLCBBaG1lZCBNLg==|https://frl.publisso.de/adhoc/uri/TcO8bGxlciwgTWFyY2VsIEEu|https://frl.publisso.de/adhoc/uri/QmxlaWNrZXIsIFRvYmlhcw==|https://frl.publisso.de/adhoc/uri/SGFyYWtlaCwgU3RldmUgTS4=|https://frl.publisso.de/adhoc/uri/QWx6YWhyYW5pLCBBYmR1bHJhaG1hbiBBLg==|https://frl.publisso.de/adhoc/uri/QWxzYWFpZGksIEdoYWxlYiBBLg==|https://frl.publisso.de/adhoc/uri/QWxhZ2lsaSwgQWJkdWxheml6IE4u|https://frl.publisso.de/adhoc/uri/SGFzaGVtLCBBbndhciBNLg==|https://frl.publisso.de/adhoc/uri/WnVtbGEsIEFsaW11ZGRpbg==|https://orcid.org/0000-0001-7923-0519|https://frl.publisso.de/adhoc/uri/QXpoYXIsIEVzYW0gSS4=
1000 Label
1000 Förderer
  1. Bundesministerium für Bildung und Forschung |
  2. Horizon 2020 Framework Programme |
  3. Emerging Diseases Clinical Trials Partnership |
1000 Fördernummer
  1. -
  2. -
  3. -
1000 Förderprogramm
  1. -
  2. -
  3. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Bundesministerium für Bildung und Forschung |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Horizon 2020 Framework Programme |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Emerging Diseases Clinical Trials Partnership |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6419858.rdf
1000 Erstellt am 2020-04-08T08:34:19.308+0200
1000 Erstellt von 25
1000 beschreibt frl:6419858
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Fri Feb 12 09:35:07 CET 2021
1000 Objekt bearb. Fri Feb 12 09:35:06 CET 2021
1000 Vgl. frl:6419858
1000 Oai Id
  1. oai:frl.publisso.de:frl:6419858 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source